Abstract:OBJECTIVE:The bone marrow mesenchymal stem cells (BMSCs) have the capacity to differentiate into insulin-producing cells (IPCs) in vitro. However, low differentiation efficiency and poor maturity are the main obstacles. To investigate the feasibility of BMSCs differentiation into IPCs in diabetic pancreatic microenvironment of pigs. METHODS:BMSCs were isolated and purified from the bone marrow of a 4-week-old male pig. Fifteen female pigs (aged 8 to 10 weeks, weighing 8 to 10 kg) were randomly divided into 3 groups: normal control group (group A, n=5), diabetic control group (group B, n=5), and BMSCs transplanted group (group C, n=5). The pigs of groups B and C were treated by auris vein injections of streptozocin and alloxan for 3 days to induce diabetes mellitus (DM) model, whose blood glucose level 2 days all greater than 17 mmol/L was successful DM model. A total of 1.1 mL of the 3rd passage BMSCs labeled with enhanced green fluorescent protein (EGFP), with cell density of 5 x 10(7)/ mL, were injected into subcapsular pancreas of group C at multiple points, normal saline at the same dosage into those of groups A and B. After 30 days of monitoring blood glucose, the histological analysis of islet number and size were done; the immunofluorescence staining was used to detect the protein expression of insulin in the new-formed islets. The EGFP+ cells were collected from the sections using laser-capture microdissection; RT-PCR was used to detect insulin mRNA and pancreatic and duodenal homeobox factor 1 (PDX1) mRNA expressions from EGFP+ cells, and the insulin and sex determining region of the Y chromosome (SRY) genes were detected by fluorescence in situ hybridization (FISH). RESULTS:The blood glucose level decreased significantly in group C when compared with that in group B from 18 days and gradually decreased with time (P < 0.05). The histological observation showed that the number of islets was increased significantly in group C when compared with that in group B (10.9 +/- 2.2 vs. 4.6 +/- 1.4, P < 0.05), and there was no significant difference when compared with that in group A (10.9 +/- 2.2 vs.12.6 +/- 2.6, P > 0.05). The size of new-formed islets in group C was significantly smaller than that in group A [(47.2 +/- 19.6) microm vs. (119.6 +/- 27.7) microm, P < 0.05]. The immunofluorescence staining showed that new-formed islets of group C expressed insulin protein. RT-PCR showed that the microdissected EGFP+ cells of group C expressed insulin mRNA and PDX-1 mRNA. FISH showed that the new-formed islet cells of group C contained SRY gene in Y chromosome and insulin double positive cells. CONCLUSION:BMSCs can differentiate into IPCs in diabetic pancreatic microenvironment of pigs.

Differentiation of multipotent stem cells to insulin-producing cells for treatment of diabetes mellitus: bone marrow- and adipose tissue-derived cells comparison

From Mesenchymal Stromal/Stem Cells to Insulin-Producing Cells: Progress and Challenges

Differentiation of bone marrow mesenchymal stem cells into insulin-producing cells: A dynamic observation

Differentiation of human adipose-derived stem cells into islet beta-like cells in vitro

Comparative Study of Three Types of Mesenchymal Stem Cell to Differentiate into Pancreatic Β-Like Cells in Vitro.

Effective Generation of Functional Pancreatic β Cells from Human-Derived Dental Stem Cells of Apical Papilla and Bone-Marrow-Derived Stem Cells: A Comparative Study

Recent progress in differentiation of mesenchymal stem cells into islet-like cells

Insulin-Producing Cells Differentiated from Human Bone Marrow Mesenchymal Stem Cells in Vitro Ameliorate Streptozotocin-Induced Diabetic Hyperglycemia

IN VITRO TRANSDIFFERENTIATION OF RAT BONE MARROW MESENCHYMAL STEM CELLS INTO INSULIN-SECRETING CELLS

Bone Marrow Mesenchymal Stem Cells Orthotopictransplantation Reverse Diabetes

Human bone marrow mesenchymal stem cells differentiate into insulin-producing cells upon microenvironmental manipulation in vitro.

[Feasibility of Bone Marrow Mesenchymal Stem Cells Differentiation in Diabetic Pancreatic Microenvironment].

Transplantation of Betatrophin-Expressing Adipose-Derived Mesenchymal Stem Cells Induces Β-Cell Proliferation in Diabetic Mice

In Vitro Differentiation of Human Adipose Tissue-Derived Stromal Cells into Insulin-Producing Cells

Coexpression of Pdx1 and betacellulin in mesenchymal stem cells could promote the differentiation of nestin-positive epithelium-like progenitors and pancreatic islet-like spheroids.

Studies on Coexpression of PDX1 and Betacellulin in Bone Marrow Mesen-chymal Stem Cells Differentiating into Insulin-secreting Cells

Direct Differentiation of Bone Marrow Mononucleated Cells Into Insulin-Producing Cells Using 4 Specific Soluble Factors

Current status of stem cell therapy for type 1 diabetes: a critique and a prospective consideration

Mesenchymal Stem Cells Ameliorate Β Cell Dysfunction of Human Type 2 Diabetic Islets by Reversing Β Cell Dedifferentiation

Vitamin D supplementation affects bone marrow-derived mesenchymal stem cells differentiation into insulin-producing cells

Study of Differentiation of Mesenchymal Stem Cell into Islet - Like Cells and Function of Islet - Like Cells